Treace Announces Participation in Two Upcoming Investor Conferences
Globenewswire· 2025-11-07 21:05
PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced it will participate in the following upcoming investor conferences. The UBS Global Healthcare Conference on Monday, November 10, 2025, with a fireside chat at 11:45 am ET; andThe Stifel 2025 Healthcare Conference on Tuesday, November 11, 20 ...
International Tower Hill Mines Files 2025 Third Quarter Financial Results
Prnewswire· 2025-11-07 21:05
Accessibility StatementSkip Navigation more press release views with Request a Demo VANCOUVER, BC, Nov. 7, 2025 /PRNewswire/ - International Tower Hill Mines Ltd. (the "Company") - (TSX: ITH) (NYSE American: THM) today announced that it has filed its unaudited third quarter Financial Statements and associated Management Discussion and Analysis and Quarterly Report on Form 10-Q for the three- and nine-month period ended September 30, 2025. Shareholders can obtain copies of the Company's unaudited third quar ...
IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment
Globenewswire· 2025-11-07 21:05
Investors and stakeholders invited to attend in person in New York City or via live webcast on Monday, November 10th at 8:00 a.m. ET LAWRENCEVILLE, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with its DNA-mediated immunotherapy, will host an R&D Day on Monday, November 10, 2025 at 8:00 a.m. ET in New York City featuring in-depth discussions with experts including principal investigators leading the Phase 3 OVATION 3 clinical trial and ...
Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025
Globenewswire· 2025-11-07 21:05
AI-based digital pathology analysis provides high-resolution quantification of hepatic fibrosis and objective measurement of fibrosis improvement Pemvidutide demonstrated significant reductions in liver fibrosis and improvements in non-invasive tests vs. placebo at 24 weeks GAITHERSBURG, Md., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced resu ...
股票行情快报：开立医疗（300633）11月7日主力资金净卖出271.15万元
搜狐财经· 2025-11-07 21:04
11月7日的资金流向数据方面，主力资金净流出271.15万元，占总成交额2.77%，游资资金净流入918.55 万元，占总成交额9.4%，散户资金净流出647.39万元，占总成交额6.62%。 近5日资金流向一览见下表： 证券之星消息，截至2025年11月7日收盘，开立医疗(300633)报收于28.84元，下跌0.07%，换手率 0.78%，成交量3.4万手，成交额9772.96万元。 开立医疗2025年三季报显示，前三季度公司主营收入14.59亿元，同比上升4.37%；归母净利润3351.11 万元，同比下降69.25%；扣非净利润2399.1万元，同比下降72.14%；其中2025年第三季度，公司单季度 主营收入4.95亿元，同比上升28.42%；单季度归母净利润-1351.92万元，同比上升78.05%；单季度扣非 净利润-1588.57万元，同比上升76.92%；负债率24.22%，投资收益207.82万元，财务费用-3830.36万 元，毛利率60.36%。开立医疗（300633）主营业务：医疗诊断及治疗设备的自主研发、生产与销售。 该股最近90天内共有22家机构给出评级，买入评级14家，增持评级 ...
股票行情快报：顺丰控股（002352）11月7日主力资金净买入1514.86万元
搜狐财经· 2025-11-07 21:04
证券之星消息，截至2025年11月7日收盘，顺丰控股(002352)报收于39.98元，下跌0.12%，换手率 0.62%，成交量29.68万手，成交额11.89亿元。 11月7日的资金流向数据方面，主力资金净流入1514.86万元，占总成交额1.27%，游资资金净流出 2962.92万元，占总成交额2.49%，散户资金净流入1448.07万元，占总成交额1.22%。 近5日资金流向一览见下表： | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-11-07 | 39.98 | -0.12% | 1514.86万 | 1.27% | -2962.92万 | -2.49% | 1448.07万 | 1.22% | | 2025-11-06 | 40.03 | 1.01% | 6423.16万 | 4.54% | -3031.35万 | -2.14% | -3391.81万 | -2.40% | | 2025-11-05 ...
股票行情快报：泰山石油（000554）11月7日主力资金净卖出1865.69万元
搜狐财经· 2025-11-07 21:04
证券之星消息，截至2025年11月7日收盘，泰山石油(000554)报收于7.06元，下跌0.14%，换手率 4.37%，成交量15.84万手，成交额1.12亿元。 | | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-11-07 | 7.06 | -0.14% | -1865.69万 | -16.62% | -108.08万 | -0.96% | 1973.77万 | - 17.59% | | 2025-11-06 | 7.07 | 0.43% | -698.44万 | -5.21% | -856.27万 | -6.39% | 1554.70万 | 11.60% | | 2025-11-05 | 7.04 | 2.03% | -282.06万 | -1.60% | -187.60万 | -1.06% | 469.66万 | 2.66% | | 2025-11-04 | 6.90 | 0.00% | 796.60万 | ...
中英科技(300936.SZ)股东马龙秀拟减持不超58万股
智通财经网· 2025-11-07 21:04
智通财经APP讯，中英科技(300936.SZ)发布公告，持有公司股份58万股(占公司总股本比例的0.7713%) 的公司控股股东、实际控制人的一致行动人马龙秀先生计划通过集中竞价交易方式或大宗交易方式减持 公司股份不超过58万股，即不超过公司总股本的0.7713%，减持期间自本减持计划公告之日起15个交易 日后3个月内进行(即2025年12月1日-2026年2月28日)。 ...
全国首个“以房管安”系统在南京上线 “AI+三维”破解复杂业态安全监管难题
扬子晚报网· 2025-11-07 21:04
每栋监管建筑均被赋予唯一"数字身份证码"；当建筑内业态冲突存在风险时，将自动触发预警实现风险事前阻断……全国首个"以房管安"信息化系统（一 期），在南京正式上线试运行。 该系统依托南京市时空大数据及"181"应急管理等信息化平台，针对"厂中厂"、多业态商业体（不含高层建筑）、经营性自建房等三大高风险场景，构建 起全链条安全治理体系，为城市安全消防风险管控探索了新思路。 "以房管安"系统页面 从"管企业"到"管空间" "近年来国内发生的多起火灾事故，暴露出多业态混合生产经营场所风险交织叠加的普遍难题。深刻汲取相关教训，在系统设计之初，就将破解此类场景 的安全监管困境作为核心目标。"南京市安委办负责人在介绍系统设计初衷时指出，传统监管往往以"单个企业"为重点，面对多出租方与多承租方并存、 业态多样、租赁频繁的场景，极易出现底数不清、风险辨识碎片化、责任断裂、协同不足等问题。 为此，南京市安委办联合市规划资源局、市数据局等部门，携手擎天科技等企业共同打造"以房管安"信息化系统，将安全管理基本单元从"企业"延伸至固 定的"建筑空间"，通过"建筑有码、管理有人、巡查有单、责任有链"的闭环设计，精准破解治理痛点。截至目前 ...
